CBM Lifemotion

Why Us

Why Choose CBM?

Why Healthcare Teams Choose Lifemotion®

At CBM Lifemotion®, we design ECMO systems for proven performance in the ICU, during patient transport, and in emergency situations.
Our approach combines advanced engineering with rigorous safety standards, user‑tested interfaces, and performance validated for demanding clinical environments.

Complete Supply Chain Control

CBM is one of the few companies in the ECMO industry that controls the entire supply chain. Unlike many competitors who depend on external suppliers, we manufacture every key component in-house. This autonomy supports high quality, consistent production, and dependable reliability—even during global supply chain challenges.

Innovative Production in Italy

Our international operations are based in Mirandola, Italy, a recognized European hub for medical device manufacturing. Our ECMO devices are produced in an ISO‑certified clean room facility, meeting strict EU MDR requirements and internationally recognised standards for safety, engineering innovation, and quality control.

Innovative ECMO Technology

CBM’s ECMO system is among China’s first fully self-developed solutions, representing a new stage in locally engineered life-support technology. Designed for portability, accessibility, and precision, it supports healthcare providers in delivering advanced critical care across a wider range of clinical settings

Tailored Solutions for Critical Care

At CBM, we don’t just offer products — we provide comprehensive solutions adapted to the specific requirements of critical care settings. By working closely with healthcare partners, we align our ECMO technology with the needs defined for each approved care environment within its intended use.

Why CBM Stands Out

Your Partner in Innovation 
and Impact

By choosing CBM, you gain access to the latest ECMO technology while supporting a mission to enhance patient outcomes. Together, we are transforming healthcare, making life-saving treatments accessible 
to all.

Lifemotion® ECMO is now approved by leading regulatory bodies across Europe, Latin America, Africa, and Asia — including CE Mark (EU), ISP (Chile), SAHPRA (South Africa ), MDD (Hong Kong), and MHRA (UK). Delivering safe, reliable, and advanced care for critically ill patients worldwide.